Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

BIOBAC ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.1% 1.1%   Bankruptcy risk   5.3% 20.6% 16.9% 15.1% 20.7% 16.9% 16.0% 16.0%   Credit score (0-100)   43 6 10 12 4 9 12 12   Credit rating   BBB B BB BB B BB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 -0.0 -0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   161 -86.6 66.7 16.8 -44.7 -71.9 0.0 0.0   EBITDA   55.7 -151 16.1 -33.9 -107 -83.4 0.0 0.0   EBIT   55.7 -151 16.1 -33.9 -107 -83.4 0.0 0.0   Pre-tax profit (PTP)   51.6 -153.4 12.1 -33.4 -107.1 -83.6 0.0 0.0   Net earnings   51.6 -153.4 12.1 -33.4 -107.1 -83.6 0.0 0.0   Pre-tax profit without non-rec. items   51.6 -153 12.1 -33.4 -107 -83.6 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   233 79.8 91.9 58.5 -48.5 -132 -257 -257   Interest-bearing liabilities   65.8 108 99.1 127 168 107 257 257   Balance sheet total (assets)   462 301 289 219 166 31.7 0.0 0.0   Net Debt   32.9 32.6 8.1 112 164 92.5 257 257     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   161 -86.6 66.7 16.8 -44.7 -71.9 0.0 0.0   Gross profit growth   -55.9% 0.0% 0.0% -74.8% 0.0% -60.9% 0.0% 0.0%   Employees   0 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   462 301 289 219 166 32 0 0   Balance sheet change%   7.4% -34.7% -4.1% -24.3% -23.9% -81.0% -100.0% 0.0%   Added value   55.7 -150.7 16.1 -33.9 -107.0 -83.4 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 -1.0 1.0 -1.0 -2.0 -3.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   34.6% 174.1% 24.2% -201.0% 239.5% 116.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   12.5% -39.5% 5.6% -13.0% -49.1% -44.1% 0.0% 0.0%   ROI %   20.8% -61.9% 8.8% -17.5% -60.2% -60.7% 0.0% 0.0%   ROE %   24.9% -98.0% 14.1% -44.4% -95.3% -84.5% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   50.5% 26.5% 31.8% 26.8% -22.6% -80.6% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   59.1% -21.6% 50.0% -330.5% -153.2% -110.9% 0.0% 0.0%   Gearing %   28.2% 135.3% 107.8% 217.2% -346.0% -81.1% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   6.8% 3.3% 4.3% 0.3% 0.5% 0.2% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.2 0.4 0.5 0.1 0.0 0.1 0.0 0.0   Current Ratio   2.0 1.4 1.5 1.4 0.8 0.2 0.0 0.0   Cash and cash equivalent   32.9 75.3 91.0 15.2 4.0 14.3 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   233.2 79.8 91.9 58.5 -48.5 -131.6 -128.3 -128.3   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 -151 16 -34 -107 -83 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 -151 16 -34 -107 -83 0 0   EBIT / employee   0 -151 16 -34 -107 -83 0 0   Net earnings / employee   0 -153 12 -33 -107 -84 0 0